Success Metrics

Clinical Success Rate
100.0%

Based on 16 completed trials

Completion Rate
100%(16/16)
Active Trials
13(41%)
Results Posted
13%(2 trials)

Phase Distribution

Ph phase_3
1
3%
Ph early_phase_1
6
19%
Ph phase_2
4
13%
Ph not_applicable
5
16%
Ph phase_1
16
50%

Phase Distribution

22

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution32 total trials
Early Phase 1First-in-human
6(18.8%)
Phase 1Safety & dosage
16(50.0%)
Phase 2Efficacy & side effects
4(12.5%)
Phase 3Large-scale testing
1(3.1%)
N/ANon-phased studies
5(15.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

16 of 16 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

13

trials recruiting

Total Trials

32

all time

Status Distribution
Active(16)
Completed(16)

Detailed Status

Completed16
Recruiting12
Not yet recruiting3
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
13
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 16 (18.8%)
Phase 116 (50.0%)
Phase 24 (12.5%)
Phase 31 (3.1%)
N/A5 (15.6%)

Trials by Status

active_not_recruiting13%
recruiting1238%
completed1650%
not_yet_recruiting39%

Recent Activity

13 active trials
Showing 5 of 32
recruitingphase_2

Cannabis (THC vs. CBD) in Multiple Sclerosis

NCT06261489
recruitingphase_1

Evaluation of Oral THC and CBD in Men and Women

NCT05067387
completedphase_1

A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers

NCT07146945
recruitingphase_1

The Pharmacokinetics of a Hemp-Based Topical Product

NCT07603518
not_yet_recruitingphase_1

Behavioral Pharmacology of THC and Beta-Myrcene

NCT05432284
View all 32 trials

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT06261489Phase 2

Cannabis (THC vs. CBD) in Multiple Sclerosis

Recruiting
NCT05067387Phase 1

Evaluation of Oral THC and CBD in Men and Women

Recruiting
NCT07146945Phase 1

A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers

Completed
NCT07603518Phase 1

The Pharmacokinetics of a Hemp-Based Topical Product

Recruiting
NCT05432284Phase 1

Behavioral Pharmacology of THC and Beta-Myrcene

Not Yet Recruiting
NCT06878417Not Applicable

Cannabinoids for Osteoarthritis Pain Effectiveness Trial

Recruiting
NCT07656350Not Applicable

Challenging the Endocannabinoid System in Sleep Restricted Healthy Volunteers to Modulate Physiological Arousal (CANISLEEP) Study

Recruiting
NCT05322213Phase 1

THC Effects on Glucose in Type 2 Diabetes

Recruiting
NCT05514899Phase 2

Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV

Recruiting
NCT02407808Phase 1

Cannabinoids, Learning, and Memory

Active Not Recruiting
NCT05052541Phase 3

Safety and Efficacy of Oral Cannabis in Chronic Spine Pain

Recruiting
NCT06859710Phase 1

THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy

Recruiting
NCT06647524Phase 2

Pilot fMRI Studies of Aging-Related Effects of THC

Recruiting
NCT06758596Early Phase 1

Research Investigating Drug Effects-2 (RiDE-2)

Not Yet Recruiting
NCT02781519Phase 1

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans

Recruiting
NCT05641766Phase 2

Multimodal Magnetoencephalography and Electroencephalography Exploration of the Acute Effects of THC Exposure on Neural Noise and Information Transmission Within Working Memory Networks

Not Yet Recruiting
NCT04130633Phase 1

Behavioral Pharmacology of THC and Alpha-pinene

Completed
NCT04512365Early Phase 1

Reward and Drug Effects on Mood and Brain Response

Completed
NCT01853020Early Phase 1

Cannabinoids and Cerebellar-Motor Functioning

Completed
NCT04283019Phase 1

The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32